Contribution of α2 receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine

British Journal of Pharmacology

Volumn 132, Issue 8, 2001, Pages 1827-1836

  Malmberg, Annika B ^a,b   Hedley, Linda R ^c   Jasper, Jeffrey R ^c   Hunter, John C ^c   Basbaum, Allan I ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROCHE BIOSCIENCE   (United States)

Author keywords

Antinociception; Guanethidine sympathectomy; Neuropathic pain; Peripheral nerve injury; Thermal and mechanical allodynia; adrenergic receptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; DEXMEDETOMIDINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; NONHUMAN; PAIN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; WITHDRAWAL REFLEX;

EID: 0035038030     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704032     Document Type: Article

References (70)

1. Uninjured C-fiber nociceptors develop spontaneous activity and adrenergic sensitivity following L6 spinal nerve ligation in monkey
2. Intravenous phentolamine test: Diagnostic and prognostic use in reflex sympathetic dystrophy
3. Expression of alpha2-adrenergic receptors in rat primary afferent neurones after peripheral nerve injury or inflammation
4. Causalgia and other reflex sympathetic dystrophies
5. Discharge of tritium-labeled guanethidine by sympathetic nerve stimulation as evidence that guanethidine is a false transmitter
6. International Union of Pharmacology nomenclature of adrenoceptors
7. Quantitative assessment of tactile allodynia in the rat paw
8. Adrenoceptor subtype mediating sympathetic-sensory coupling in injured sensory neurons
9. Changes in the alpha 2-adrenergic receptor subtypes gene expression in rat dorsal root ganglion in an experimental model of neuropathic pain
10. Structure-affinity relationships of 12-sulfonyl derivatives of 5,8,8A,9,10,11,12,12a,13,13a-decahydro-6h-isoquino[2,1-g][1,6] naphthyridines at alpha-adrenoceptors
11. Pharmacological discrimination of N-type from L-type calcium current and its selective modulation by transmitters
12. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain
13. Influence of the sympathetic nervous system in the development of abnormal pain-related behaviours in a rat model of neuropathic pain
14. Modulation of activity in dorsal root ganglion neurons by sympathetic activation in nerve-injured rats
15. Activation of myelinated afferents ending in a neuroma by stimulation of the sympathetic supply in the rat
16. Alpha 1-adrenoceptors in normal and hyperalgesic human skin
17. Alpha-2 adrenergic agonists for regional anesthesia
18. Identification and increased expression of a novel alpha-2 adrenoceptor mRNA in a rat model of experimental painful neuropathy
19. Antinociceptive properties of intrathecal dexmedetomidine in rats
20. Alpha 2-adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion neurons
21. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
22. G proteins couple alpha-adrenergic and GABAb receptors to inhibition of peptide secretion from peripheral sensory neurons
23. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice
24. Intrathecal morphine in mice: A new technique
25. 35S]GTPgammaS binding
26. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma
27. Biochemical and functional evaluation of the sympathectomy produced by the administration of guanethidine to newborn rat
28. Spinal antinociception by dexmedetomidine, a highly selective alpha 2-adrenergic agonist
29. Comparison of three rodent neuropathic pain models
30. Sympathectomy alleviates mechanical allodynia in an experimental animal model for neuropathy in the rat
31. Effects of sympathectomy on a rat model of peripheral neuropathy
32. Noradrenergic inhibition of the release of substance P from the primary afferents in rabbit spinal dorsal horn
33. Substitution of a mutant alpha2a-adrenergic receptor via 'hit and run' gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo
34. Intrathecal neostigmine, but not sympathectomy, relieves mechanical allodynia in a rat model of neuropathic pain
35. Strain differences in adrenergic sensitivity of neuropathic pain behaviors in an experimental rat model
36. 2-adrenergic receptor subtypes b and c
37. 2a-adrenergic receptor subtype
38. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: Behavioral and neuroanatomical correlates
39. Pharmacology of [2-(octahydro-l-azovinyl)-ethyl]-guanidine sulfate (guanethidine)
40. Nerve injury triggers noradrenergic sprouting within dorsal root ganglia
41. Sympathetic modulation of activity in rat dorsal root ganglion neurons changes over time following peripheral nerve injury
42. Effects of guanethidine on sensitization to natural stimuli and self-mutilating behaviour in rats with a peripheral neuropathy
43. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: An in situ hybridization study
44. Morphine and norepinephrine, but not 5-hydroxytryptamine and gamma-aminobutyric acid inhibit the potassium-stimulated release of substance P from rat spinal cord slices
45. The spinal analgesic role of alpha 2-adrenoceptor subtypes in rats after peripheral nerve section
46. Systemic alpha-adrenergic blockade with phentolamine: A diagnostic test for sympathetically maintained pain
47. Spinal cord pharmacology of adrenergic agonist-mediated antinociception
48. Mechanical hyperalgesia after spinal nerve ligation in rat is not reversed by intraplantar or systemic administration of adrenergic antagonists
49. Lumbar sympathectomy failed to reverse mechanical allodynia- and hyperalgesia-like behavior in rats with L5 spinal nerve injury
50. Distribution of alpha 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system
51. Immunohistochemical localization of alpha 2A-adrenergic receptors in catecholaminergic and other brainstem neurons in the rat
52. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury
53. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury
54. Development of ongoing activity, mechanosensitivity and adrenaline sensitivity in severed peripheral axons
55. Distribution and regulation of alpha(2)-adrenoceptors in rat dorsal root ganglia
56. Effects of sympathectomy in a model of causalgiform pain produced by partial sciatic nerve injury in rats
57. Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord
58. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy
59. Effects of peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat spinal cord
60. A point mutation of the alpha 2-adrenoceptor that blocks coupling to potassium but not calcium currents
61. Release of calcitonin gene-related peptide (CGRP), substance P (SP), and vasoactive intestinal polypeptide (VIP) from rat spinal cord: Modulation by alpha 2 agonists
62. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats
63. Epidural clonidine produces analgesia
64. Peripheral hyperalgesia in experimental neuropathy: Mediation by a2-adrenoreceptors on post-ganglionic sympathetic terminals
65. Sciatic cryoneurolysis in rats: A model of sympathetically independent pain, Part 1: Effects of sympathectomy
66. Effects of the alpha 2-adrenoceptor agonist UK14304 on pressor responses in pithed rats
67. Functional changes in dorsal root ganglion cells after chronic nerve constriction in the rat
68. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing
69. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists